Skip to main content
. 2018 Sep 30;37(3):248–256. doi: 10.23876/j.krcp.2018.37.3.248

Figure 1. Prevalence of anti-PLA2R ab in patients with membranous nephropathy (MN).

Figure 1

Anti-PLA2R ab, anti-phospholipase A2 receptor antibody; SLE, systemic lupus erythematosus; UPCR, urine protein/creatinine ratio.